Insights

US Expansion Rentschler Biopharma is actively expanding its Milford, Massachusetts facility with a new production line, including cleanroom space and single-use bioreactors, signaling a strong opportunity to upsell CDMO services to US-based biopharma clients seeking onshore manufacturing and scale-up support.

Leadership Growth Recent executive appointments including a new CEO and COO, plus a head of US Business Development, indicate a strategic push to accelerate commercial activities and client acquisition in North America, suggesting prospects for renewed outreach and partnership proposals.

FDA Track Record With a history of contributing to a significant share of FDA-approved biologics and ongoing regulatory support capabilities, there is a strong cross-sell opportunity to biotech firms aiming for rapid regulatory pathways and reliable CDMO collaboration from concept through approval.

Sustainability Angle Joining the United Nations Global Compact underscores a commitment to sustainability, presenting an opening to engage with sustainability-conscious biopharma companies seeking responsible manufacturing partners with robust governance and ethical standards.

Strategic US Focus Milford expansion and the US-centric leadership appointments align with a near-term objective to bring development and manufacturing closer to US clients, creating direct sales opportunities with biotech firms prioritizing domestic supply chains and faster time-to-market.

Similar companies to Rentschler Biopharma

Rentschler Biopharma Tech Stack

Rentschler Biopharma uses 8 technology products and services including Google Ads, Microsoft SharePoint, Azure DevOps, and more. Explore Rentschler Biopharma's tech stack below.

Media & News

Rentschler Biopharma's Email Address Formats

Rentschler Biopharma uses at least 4 email formats:
Rentschler Biopharma Email FormatsExamplePercentage
First.Last@rentschler-biopharma.comJohn.Doe@rentschler-biopharma.com
99%
Last@rentschler-biopharma.comDoe@rentschler-biopharma.com
1%
First.Last@rentschler.deJohn.Doe@rentschler.de
99%
Last@rentschler.deDoe@rentschler.de
1%

Frequently Asked Questions

What is Rentschler Biopharma's official website and social media links?

Minus sign iconPlus sign icon
Rentschler Biopharma's official website is rentschler-biopharma.com and has social profiles on LinkedIn.

How much revenue does Rentschler Biopharma generate?

Minus sign iconPlus sign icon
As of October 2026, Rentschler Biopharma's annual revenue is estimated to be $100M - $250M.

What is Rentschler Biopharma's SIC code and NAICS code?

Minus sign iconPlus sign icon
Rentschler Biopharma's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Rentschler Biopharma have currently?

Minus sign iconPlus sign icon
As of October 2026, Rentschler Biopharma has approximately 924 employees across 3 continents, including Europe, North America and Asia. Key team members include Cbo: F. T., Chief Operating Officer: C. B. and Chief Financial Officer: G. V. V. D. Explore Rentschler Biopharma's employee directory with LeadIQ.

What industry does Rentschler Biopharma belong to?

Minus sign iconPlus sign icon
Rentschler Biopharma operates in the Biotechnology Research industry.

What technology does Rentschler Biopharma use?

Minus sign iconPlus sign icon
Rentschler Biopharma's tech stack includes Google Ads, Microsoft SharePoint, Azure DevOps, Microsoft 365, ADP, Cisco, VMware and Atlassian Confluence.

What is Rentschler Biopharma's email format?

Minus sign iconPlus sign icon
Rentschler Biopharma's email format typically follows the pattern of First.Last@rentschler-biopharma.com. Find more Rentschler Biopharma email formats with LeadIQ.

How much funding has Rentschler Biopharma raised to date?

Minus sign iconPlus sign icon
As of October 2026, Rentschler Biopharma has raised $1.6M in funding. The last funding round occurred on May 18, 2016.

When was Rentschler Biopharma founded?

Minus sign iconPlus sign icon
Rentschler Biopharma was founded in 1927.
Rentschler Biopharma logo

Rentschler Biopharma

Biotechnology ResearchBaden-Württemberg, Germany501-1000 Employees

Rentschler Biopharma is a biotechnology research-focused contract development and manufacturing organization (CDMO) that serves exclusively client projects. It provides process development and manufacturing of biopharmaceuticals, along with consulting, project management, and regulatory support. The company emphasizes a high-quality management system, operational excellence, and advanced technologies to ensure product quality and productivity across development and manufacturing. It is a family-owned company headquartered in Laupheim, Germany, with operations in Milford, Massachusetts, USA. The organization lists a workforce of 501-1000 employees. In 2023, it contributed to nearly 25% of all FDA-approved biologics, and in 2024 it joined the United Nations Global Compact, reflecting a sustainability focus.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1927
Employees
501-1000

Section iconFunding & Financials

  • $1.6M

    Rentschler Biopharma has raised a total of $1.6M of funding over 1 rounds. Their latest funding round was raised on May 18, 2016 as a Series A.

  • $100M - $250M

    Rentschler Biopharma's revenue is estimated to be in the range of $100M - $250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.